Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Vitiligo Surgery Techniques and Outcomes
Description
In this presentation, Dr. Elsafatham Zavi discusses various surgical techniques for treating vitiligo, emphasizing the effectiveness of procedures like non-cultured epidermal suspension surgery (MKTP), punch grafting, and blister grafting. He highlights the importance of patient stability and the right selection for surgery, noting that active depigmentation is a poor candidate for such interventions. The talk features an overview of surgical methodologies, including the preparation of donor skin and recipient sites using dermabrasion or CO2 lasers. Zavi provides insights into the expected outcomes, illustrating that areas like the face generally respond better than tips of fingers or toes. Furthermore, he discusses long-term outcomes and the role of adjuvant therapies, alongside improvements in surgical kits that simplify procedures. Zavi concludes with an emphasis on the high satisfaction rates among patients and urges practitioners to consider surgical options for vitiligo, as they can lead to rapid and significant repigmentation results. He also commemorates the contributions of Dr. Sanjeev Mullikar in this field.
View moreConclusions
- Surgery is a viable option for treating stable vitiligo, especially non-segmental types.
- Patient selection is crucial, with segmental vitiligo showing better responses than generalized forms.
- The presence of CD8 lymphocytes can predict surgical outcomes for vitiligo surgeries.
- Different surgical techniques, including punch grafting and MKTP, yield varying repigmentation rates, with MKTP showing 70-90% success in stable areas.
- Surgery may not be effective for high-density CD8 lymphocyte areas or regions like fingertips and toes.
- Adjuvant therapies may enhance outcomes but are not always necessary.
- Surgical results can take time to manifest, ranging from weeks to months, with a continued improvement over the years.
- Patients should have realistic expectations about the level of repigmentation achievable through surgery, as not everyone will reach full repigmentation.
- Studies indicate that surgery can lead to high levels of patient satisfaction despite the variability of results.
- Refat MA, Harris JE. Lesional CD8+ T-Cell Number Predicts Surgical Outcomes of Melanocyte-Keratinocyte Transplantation Surgery for Vitiligo. J Invest Dermatol. 2023.
- Huggins RH, Henderson M et al. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: The experience of an academic medical center in the United States. J Am Acad Derm. 2012 May;66(5):785-93.
- van Geel N, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2173-2184.
- Hamzavi IH, et al. J Am Acad Dermatol. 2024 Dec;91(6):1104-1112.
- Gan EY et al. J Am Acad Dermatol 2016; 75(3):564-71.
- Ju HJ, Bae JM, Lee RW, Kim SH, Parsad D, Pourang A, Hamzavi I, Shourick J, Ezzedine K. Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis. JAMA Dermatol. 2021 Mar.
- Narayan VS. Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review. J Eur Acad Dermatol Venereol. 2021.
- Maghfour J, et al. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review. Dermatology. 2023.